Published in Health and Medicine Week, July 11th, 2005
Pelzel, a proven biotechnology and pharmaceutical executive, brings to Depomed over 28 years of experience in discovery, development, and global commercialization of pharmaceutical products.
"We are delighted to have Carl join our team," said John W. Fara, PhD, chairman, president, and chief executive officer of Depomed. "He has an outstanding track record in sales and marketing and building commercial operations and we look forward to his insights and leadership as we make our transition into a commercial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.